相关实验视频

Updated: Jan 8, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

混合细胞外囊泡用于有效加载和功能性传递mRNA

Xiaoqin Wang^1,2, Michael J Munson², Kristina Friis²

¹Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Journal of extracellular vesicles

|December 15, 2025

概括

研究人员开发出混合细胞外囊泡 (HEVs) 用于mRNA输送. 这些HEV克服了加载挑战,并改善了细胞内mRNA输送,显示了治疗应用的前景.

科学领域:

生物技术是生物技术.
纳米医学是一种纳米医学.
分子生物学分子生物学

背景情况:

细胞外囊泡 (EVs) 是有前途的药物输送载体.
在使用EV的mRNA的加载和功能传递方面存在挑战.
脂质纳米颗粒 (LNP) 提供了替代的输送方式,但也有局限性.

研究的目的:

开发一种新的混合细胞外囊 (HEV) 平台,用于增强mRNA输送.
通过HEV研究mRNA加载和细胞内传递的机制.
评估HEV介导的mRNA输送的体内疗效和生物分布.

主要方法:

通过使用低pH诱导的聚变,将EV与LNP融合为工程混合动力电动汽车 (HEV).
使用常规方法和单颗粒分析来描述HEV.
评估了HEV细胞耐受性,mRNA加载效率和细胞内传递机制.
在临床前模型中评估了体内mRNA输送和生物分布.

主要成果:

HEV成功地结合了mRNA和LNP组件,同时保留了EV的特征.
与原生EV相比,HEVs表现出更好的细胞耐受性和高效的mRNA输送.
HEVs促进了内体逃逸,增强了细胞内mRNA的输送.
在体内研究显示,功能性肝外mRNA输送主要到脏.

结论:

混合动力电动汽车 (HEV) 是一种新的,有效的mRNA输送平台.
在mRNA治疗中,HEV克服了传统EV和LNP的关键局限性.
该HEV平台显示出在推进基于mRNA的疗法方面具有重大潜力.

关键词:

细胞耐受性细胞耐受性细胞内体逃脱的方法功能性的生物分布.功能性交付提供功能性交付杂交的细胞外囊泡.在mRNA加载时.

更多相关视频

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

相关概念视频

Regulated mRNA Transport

Regulated mRNA Transport

In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...

Nuclear Export of mRNA

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

Intralumenal Vesicles and Multivesicular Bodies

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...